CAR-T therapy could be available to NHS patients this year – PharmaTimes
PharmaTimes |
CAR–T therapy could be available to NHS patients this year
PharmaTimes NHS England chief executive Simon Stevens has indicated that chimeric antigen receptor T–cell therapy (CAR-T) could be available on the NHS this year, offering eligible patients a 'ground-breaking' approach to treating cancer. Addressing the … New CAR–T therapy could provide safer, more effective cancer treatment Risk Versus Reward: The Value of Cell Therapy for Patients and Investors |
